Cheng Zu
Impact in
- Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology
-
- CAR-T cell therapy research
Papers in
- Oncology 12
- CAR-T cell therapy research 11
-
- Immunotherapy and Immune Responses 3
- Co-authors
- Yong Zhou (4 shared papers)Chen‐Yu Zhang (4 shared papers)Hui‐Hui Yang (4 shared papers)Yongxian Hu (9 shared papers)Xinxin Guan (3 shared papers)Jia‐Xi Duan (3 shared papers)He Huang (8 shared papers)Cha‐Xiang Guan (3 shared papers)
- Journals
- Frontiers in Immunology (1 paper)BMC Cancer (1 paper)Journal of Cellular Physiology (1 paper)Cell Transplantation (1 paper)npj Vaccines (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Cheng Zu
19 papers receiving 230 citations
Peers
Comparison fields: 5 of 57
- Biochemistry 53
- Oncology 94
- Immunology 57
- Hematology 21
- Molecular Biology 90
Countries citing papers authored by Cheng Zu
This map shows the geographic impact of Cheng Zu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng Zu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng Zu more than expected).
Fields of papers citing papers by Cheng Zu
This network shows the impact of papers produced by Cheng Zu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng Zu. The network helps show where Cheng Zu may publish in the future.
Co-authors
The 25 scholars most cited alongside Cheng Zu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 45 | |
| 2 | 2020 | 41 | |
| 3 | 2023 | 33 | |
| 4 | 2021 | 18 | |
| 5 | 2023 | 16 | |
| 6 | 2022 | 14 | |
| 7 | 2023 | 13 | |
| 8 | 2022 | 13 | |
| 9 | 2023 | 10 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 6 | |
| 12 | 2025 | 4 | |
| 13 | 2022 | 4 | |
| 14 | 2022 | 3 | |
| 15 | 2023 | 3 | |
| 16 | 2024 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2025 | 1 | |
| 19 | 2022 | 1 | |
| 20 | 2024 | 0 |
About Cheng Zu
Cheng Zu is a scholar working on Oncology, Immunology, Molecular Biology, Hematology and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 234 indexed citations. Recurring topics across this work include CAR-T cell therapy research (11 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Immunotherapy and Immune Responses (3 papers), Nanowire Synthesis and Applications (2 papers), Chemotherapy-related skin toxicity (2 papers), Virus-based gene therapy research (2 papers), Hematopoietic Stem Cell Transplantation (2 papers) and Heme Oxygenase-1 and Carbon Monoxide (2 papers). The work is most often cited by research in Biochemistry (53 citations), Oncology (94 citations), Immunology (57 citations), Hematology (21 citations) and Molecular Biology (90 citations). Cheng Zu has collaborated with scholars based in China and United States. Frequent co-authors include Yong Zhou, Chen‐Yu Zhang, Hui‐Hui Yang, Yongxian Hu, Xinxin Guan, Jia‐Xi Duan, He Huang, Cha‐Xiang Guan, Chen‐Chen Sun and Jian‐Bing Xiong. Their work appears in journals such as Frontiers in Immunology, BMC Cancer, Journal of Cellular Physiology, Cell Transplantation and npj Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.